Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281190 · ClinicalTrials.gov registry record
Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 32
- Enrollment target
NCT00281190: Completed study, sponsored by University of Michigan.
NCT00281190 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281190 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the alveolar macrophages (AMø) of patients with chronic obstructive pulmonary disease (COPD ) show abnormal responsiveness to bacterial and viral products, relative to smokers with normal pulmonary function. Participation in this study will be offered to patients already scheduled to undergo a bronchoscopy for clinical indications.
Interventions
- PROCEDURE Blood drawing
- PROCEDURE Bronchoalveolar lavage during indicated bronchoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2005-09 |
| Est. Completion | 2014-10 |
What the finished NCT00281190 record still lists
NCT00281190 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood drawing is the first listed.
NCT00281190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00281190 about?
NCT00281190 is a clinical study titled "Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function". The purpose of this study is to determine whether the alveolar macrophages (AMø) of patients with chronic obstructive pulmonary disease (COPD ) show abnormal responsiveness to bacterial and viral products, relative to smokers with normal pulmonary function. Participation in this study will be offere...
What is the current status of trial NCT00281190?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2005-09. Estimated completion is 2014-10.
What interventions are being tested in trial NCT00281190?
The interventions under investigation include: Blood drawing (PROCEDURE), Bronchoalveolar lavage during indicated bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00281190?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia